↓ Skip to main content

Anti-tumour necrosis factor-α therapy and recurrent or new primary cancers in patients with inflammatory bowel disease, rheumatoid arthritis, or psoriasis and previous cancer in Denmark: a nationwide…

Overview of attention for article published in The Lancet Gastroenterology & Hepatology, December 2019
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (97th percentile)
  • High Attention Score compared to outputs of the same age and source (92nd percentile)

Mentioned by

news
1 news outlet
twitter
145 X users

Citations

dimensions_citation
45 Dimensions

Readers on

mendeley
89 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Anti-tumour necrosis factor-α therapy and recurrent or new primary cancers in patients with inflammatory bowel disease, rheumatoid arthritis, or psoriasis and previous cancer in Denmark: a nationwide, population-based cohort study
Published in
The Lancet Gastroenterology & Hepatology, December 2019
DOI 10.1016/s2468-1253(19)30362-0
Pubmed ID
Authors

Akbar K Waljee, Peter D R Higgins, Camilla B Jensen, Marie Villumsen, Shirley A Cohen-Mekelburg, Beth I Wallace, Jeffrey A Berinstein, Kristine H Allin, Tine Jess

X Demographics

X Demographics

The data shown below were collected from the profiles of 145 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 89 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 89 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 12 13%
Student > Master 9 10%
Researcher 9 10%
Student > Bachelor 7 8%
Other 7 8%
Other 18 20%
Unknown 27 30%
Readers by discipline Count As %
Medicine and Dentistry 36 40%
Biochemistry, Genetics and Molecular Biology 8 9%
Nursing and Health Professions 2 2%
Business, Management and Accounting 2 2%
Pharmacology, Toxicology and Pharmaceutical Science 2 2%
Other 6 7%
Unknown 33 37%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 101. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 25 September 2023.
All research outputs
#420,958
of 25,550,333 outputs
Outputs from The Lancet Gastroenterology & Hepatology
#121
of 1,667 outputs
Outputs of similar age
#10,121
of 478,294 outputs
Outputs of similar age from The Lancet Gastroenterology & Hepatology
#6
of 70 outputs
Altmetric has tracked 25,550,333 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,667 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 38.0. This one has done particularly well, scoring higher than 92% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 478,294 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 97% of its contemporaries.
We're also able to compare this research output to 70 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 92% of its contemporaries.